Drugs / quadrivalent recombinant norovirus vaccine (Pichia pastoris)
quadrivalent recombinant norovirus vaccine (Pichia pastoris)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06524947 | Jul 2024 → Mar 2027 expected | norovirus infectious disease | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | quadrivalent recombinant norovirus vaccine (Pichia pastoris) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06524947 ↗ |
| Modality | Vaccine | “quadrivalent recombinant norovirus vaccine (Pichia Pastoris)” NCT06524947 ↗ |